Kenalog and Vimpat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Kenalog (triamcinolone acetonide) and Vimpat (lacosamide). Common drug interactions include drug ineffective among females and graft versus host disease among males.

The phase IV clinical study analyzes what interactions people have when they take Kenalog and Vimpat. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Kenalog?

Kenalog has active ingredients of triamcinolone acetonide. It is often used in pain. eHealthMe is studying from 10,692 Kenalog users. Check the latest studies of Kenalog.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 20,831 Vimpat users. Check the latest studies of Vimpat.

On Jul, 18, 2026

25 people who take Kenalog and Vimpat together, and have interactions are studied.

What are the common drug interactions of Kenalog and Vimpat, by gender? *:

female:

Drug ineffective
Hippocampal sclerosis (neuropathological condition with severe neuronal cell loss and gliosis in the hippocampus)
Agoraphobia (extreme or irrational fear of crowded spaces or enclosed public places)
Anaphylactic reaction (serious allergic reaction)
Anxiety
Blood pressure increased
Death
Depression
General physical health deterioration (weak health status)
Headache (pain in head)

male:

Graft versus host disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body)
Headache (pain in head)
Myalgia (muscle pain)
Pleural effusion (water on the lungs)
Pyrexia (fever)
Renal failure acute (rapid kidney dysfunction)
Aortic dilatation
Apnoeic attack
Asthenia (weakness)
Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)

What are the common drug interactions of Kenalog and Vimpat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Aortic dilatation
Autism spectrum disorder (developmental disabilities that can cause significant social, communication and behavioural challenges)
Developmental delay
Drug ineffective
Hypoxia (low oxygen in tissues)
Idiopathic generalised epilepsy (epileptic disorders that are believed to have a strong underlying genetic basis)
Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)

10-19:

n/a

20-29:

n/a

30-39:

Myalgia (muscle pain)
Pyrexia (fever)
Death
Pneumonia
Psoriasis (immune-mediated disease that affects the skin)

40-49:

Agoraphobia (extreme or irrational fear of crowded spaces or enclosed public places)
Anxiety
Back pain
Cerebellar ataxia (loss of coordination)
Cerebellar atrophy (degeneration of the section of the brain responsible for balance, voluntary muscle movements)
Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
Depression
Diplopia (double vision)
Dizziness

50-59:

Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
Cardiac failure congestive
Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
Ischaemic cardiomyopathy (weakness in the muscle of the heart due to inadequate oxygen delivery to the myocardium with coronary artery disease)
Ischaemic neuropathy (functional disturbance or pathological change in the peripheral nervous system due to inadequate supply of blood)
Mitral valve incompetence (inefficient heart valve)
Pleural effusion (water on the lungs)
Renal failure acute (rapid kidney dysfunction)

60+:

Hypertransaminasaemia
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
Rhinorrhoea (watery mucus discharge from the nose)
Sneezing
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Chest pain
Cough
General physical health deterioration (weak health status)
Headache (pain in head)
Hepatotoxicity (chemical-driven liver damage)

What are the existing conditions these people have? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 9 people, 36.00%
Rashes (redness): 3 people, 12.00%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 8.00%
High Blood Pressure: 2 people, 8.00%
Chronic Myeloid Leukaemia (In Remission): 2 people, 8.00%
Brain Neoplasm Benign (non-cancerous tumour of brain): 2 people, 8.00%
Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Kenalog and Vimpat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously